{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:10:39Z","timestamp":1784437839835,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,18]],"date-time":"2018-02-18T00:00:00Z","timestamp":1518912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,18]],"date-time":"2018-02-18T00:00:00Z","timestamp":1518912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Consortium for Eosinophilic Gastrointestinal Disease Researchers","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}]},{"name":"Office of Rare Diseases Research","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011860","name":"Campaign Urging Research for Eosinophilic Disease","doi-asserted-by":"publisher","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100011860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009561","name":"American Partnership for Eosinophilic Disorders","doi-asserted-by":"crossref","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100009561","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011860","name":"Campaign Urging Research for Eosinophilic Disease","doi-asserted-by":"crossref","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}],"id":[{"id":"10.13039\/100011860","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eosinophilic Family Coalition","award":["U54 AI117804"],"award-info":[{"award-number":["U54 AI117804"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12016-018-8670-7","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T23:39:52Z","timestamp":1518910792000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Eosinophilic Esophagitis: an Important Comorbid Condition of Asthma?"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8311-596X","authenticated-orcid":false,"given":"Sandy R.","family":"Durrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A.","family":"Mukkada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa W.","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,18]]},"reference":[{"key":"8670_CR1","unstructured":"National Asthma Education and Prevention Program: Expert panel report III: guidelines for the diagnosis and management of asthma. Bethesda MNH, Lung, and Blood Institute, 2007. (NIH publication no. 08\u20134051)"},{"key":"8670_CR2","unstructured":"Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) (2006) Available from: \n                    http:\/\/www.ginasthma.org\n                    \n                  . Accessed 1 May 2017"},{"issue":"6","key":"8670_CR3","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1053\/j.gastro.2015.02.002","volume":"148","author":"ME Rothenberg","year":"2015","unstructured":"Rothenberg ME (2015) Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology 148(6):1143\u20131157. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2015.02.002","journal-title":"Gastroenterology"},{"issue":"8","key":"8670_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrgastro.2016.91","volume":"13","author":"LA Houghton","year":"2016","unstructured":"Houghton LA, Lee AS, Badri H, DeVault KR, Smith JA (2016) Respiratory disease and the oesophagus: reflux, reflexes and microaspiration. Nat Rev Gastroenterol Hepatol 13(8):445\u2013460. \n                    https:\/\/doi.org\/10.1038\/nrgastro.2016.91","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"8670_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jaci.2011.09.013","volume":"128","author":"P Hruz","year":"2011","unstructured":"Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen M, Beglinger C, Schoepfer AM, Swiss Eo Esg (2011) Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 128(6):1349\u20131350 e1345. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2011.09.013","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"8670_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.cgh.2009.06.023","volume":"7","author":"GA Prasad","year":"2009","unstructured":"Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM, Locke GR 3rd, Talley NJ (2009) Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 7(10):1055\u20131061. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2009.06.023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"8670_CR7","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jaci.2005.01.017","volume":"115","author":"D Simon","year":"2005","unstructured":"Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A (2005) Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 115(5):1090\u20131092. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2005.01.017","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"8670_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.dld.2015.08.013","volume":"47","author":"E Savarino","year":"2015","unstructured":"Savarino E, Tolone S, Caccaro R, Bartolo O, Galeazzi F, Nicoletti L, Morbin T, Zanatta L, Salvador R, Costantini M (2015) Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis. Dig Liver Dis 47(12):1033\u20131038. \n                    https:\/\/doi.org\/10.1016\/j.dld.2015.08.013","journal-title":"Dig Liver Dis"},{"issue":"6","key":"8670_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/dote.12238","volume":"28","author":"E De la Cruz-Patino","year":"2015","unstructured":"De la Cruz-Patino E, Ruiz Juarez I, Meixueiro Daza A, Grube Pagola P, Roesch-Dietlen F, Remes-Troche JM (2015) Eosinophilic esophagitis prevalence in an adult population undergoing upper endoscopy in southeastern Mexico. Dis Esophagus 28(6):524\u2013529. \n                    https:\/\/doi.org\/10.1111\/dote.12238","journal-title":"Dis Esophagus"},{"issue":"1","key":"8670_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00455-014-9574-1","volume":"30","author":"MK Elias","year":"2015","unstructured":"Elias MK, Kopacova J, Arora AS, Dierkhising RA, Enders FT, Katzka DA, Kryzer LA, Halland M, Smyrk TC, Talley NJ, Alexander JA (2015) The diagnosis of esophageal eosinophilia is not increased in the summer months. Dysphagia 30(1):67\u201373. \n                    https:\/\/doi.org\/10.1007\/s00455-014-9574-1","journal-title":"Dysphagia"},{"issue":"27","key":"8670_CR11","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.3748\/wjg.v21.i27.8433","volume":"21","author":"Y Kinoshita","year":"2015","unstructured":"Kinoshita Y, Ishimura N, Oshima N, Ishihara S (2015) Systematic review: eosinophilic esophagitis in Asian countries. World J Gastroenterol 21(27):8433\u20138440. \n                    https:\/\/doi.org\/10.3748\/wjg.v21.i27.8433","journal-title":"World J Gastroenterol"},{"issue":"10","key":"8670_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/apt.13171","volume":"41","author":"C Maradey-Romero","year":"2015","unstructured":"Maradey-Romero C, Prakash R, Lewis S, Perzynski A, Fass R (2015) The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther 41(10):1016\u20131022. \n                    https:\/\/doi.org\/10.1111\/apt.13171","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"8670_CR13","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1007\/s10620-016-4204-4","volume":"61","author":"E Mansoor","year":"2016","unstructured":"Mansoor E, Cooper GS (2016) The 2010-2015 prevalence of eosinophilic esophagitis in the USA: a population-based study. Dig Dis Sci 61(10):2928\u20132934. \n                    https:\/\/doi.org\/10.1007\/s10620-016-4204-4","journal-title":"Dig Dis Sci"},{"issue":"4","key":"8670_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cgh.2013.09.008","volume":"12","author":"ES Dellon","year":"2014","unstructured":"Dellon ES, Jensen ET, Martin CF, Shaheen NJ, Kappelman MD (2014) Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 12(4):589\u2013596 e581. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2013.09.008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"8670_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ppul.23327","volume":"51","author":"NL Krupp","year":"2016","unstructured":"Krupp NL, Sehra S, Slaven JE, Kaplan MH, Gupta S, Tepper RS (2016) Increased prevalence of airway reactivity in children with eosinophilic esophagitis. Pediatr Pulmonol 51(5):478\u2013483. \n                    https:\/\/doi.org\/10.1002\/ppul.23327","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"8670_CR16","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1053\/gast.2002.32998","volume":"122","author":"JE Teitelbaum","year":"2002","unstructured":"Teitelbaum JE, Fox VL, Twarog FJ, Nurko S, Antonioli D, Gleich G, Badizadegan K, Furuta GT (2002) Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 122(5):1216\u20131225. \n                    https:\/\/doi.org\/10.1053\/gast.2002.32998","journal-title":"Gastroenterology"},{"issue":"1","key":"8670_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00535-012-0608-x","volume":"48","author":"SA Sorser","year":"2013","unstructured":"Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H (2013) Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol 48(1):81\u201385. \n                    https:\/\/doi.org\/10.1007\/s00535-012-0608-x","journal-title":"J Gastroenterol"},{"issue":"12","key":"8670_CR18","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S1542-3565(05)00885-2","volume":"3","author":"CA Liacouras","year":"2005","unstructured":"Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown-Whitehorn T, Mamula P, Markowitz JE (2005) Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 3(12):1198\u20131206. \n                    https:\/\/doi.org\/10.1016\/S1542-3565(05)00885-2","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"8670_CR19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1111\/j.1572-0241.2007.01352.x","volume":"102","author":"R Gill","year":"2007","unstructured":"Gill R, Durst P, Rewalt M, Elitsur Y (2007) Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004). Am J Gastroenterol 102(10):2281\u20132285. \n                    https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01352.x","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"8670_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.anai.2010.03.018","volume":"104","author":"EA Erwin","year":"2010","unstructured":"Erwin EA, James HR, Gutekunst HM, Russo JM, Kelleher KJ, Platts-Mills TA (2010) Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 104(6):496\u2013502. \n                    https:\/\/doi.org\/10.1016\/j.anai.2010.03.018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"8670_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.anai.2017.02.006","volume":"118","author":"J Gonzalez-Cervera","year":"2017","unstructured":"Gonzalez-Cervera J, Arias A, Redondo-Gonzalez O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ (2017) Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 118(5):582\u2013590 e582. \n                    https:\/\/doi.org\/10.1016\/j.anai.2017.02.006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"8670_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-pathol-012615-044241","volume":"11","author":"BP Davis","year":"2016","unstructured":"Davis BP, Rothenberg ME (2016) Mechanisms of disease of eosinophilic esophagitis. Annu Rev Pathol 11(1):365\u2013393. \n                    https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044241","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"8670_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.gie.2006.03.931","volume":"64","author":"S Baxi","year":"2006","unstructured":"Baxi S, Gupta SK, Swigonski N, Fitzgerald JF (2006) Clinical presentation of patients with eosinophilic inflammation of the esophagus. Gastrointest Endosc 64(4):473\u2013478. \n                    https:\/\/doi.org\/10.1016\/j.gie.2006.03.931","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"8670_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","volume":"133","author":"GT Furuta","year":"2007","unstructured":"Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME, First International Gastrointestinal Eosinophil Research Symposium S (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133(4):1342\u20131363. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2007.08.017","journal-title":"Gastroenterology"},{"issue":"2","key":"8670_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.clim.2013.05.004","volume":"148","author":"SM Abdulnour-Nakhoul","year":"2013","unstructured":"Abdulnour-Nakhoul SM, Al-Tawil Y, Gyftopoulos AA, Brown KL, Hansen M, Butcher KF, Eidelwein AP, Noel RA, Rabon E, Posta A, Nakhoul NL (2013) Alterations in junctional proteins, inflammatory mediators and extracellular matrix molecules in eosinophilic esophagitis. Clin Immunol 148(2):265\u2013278. \n                    https:\/\/doi.org\/10.1016\/j.clim.2013.05.004","journal-title":"Clin Immunol"},{"issue":"1","key":"8670_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1710-1492-6-25","volume":"6","author":"JJ Huang","year":"2010","unstructured":"Huang JJ, Joh JW, Fuentebella J, Patel A, Nguyen T, Seki S, Hoyte L, Reshamwala N, Nguyen C, Quiros A, Bass D, Sibley E, Berquist W, Cox K, Kerner J, Nadeau KC (2010) Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of eosinophilic esophagitis. Allergy Asthma Clin Immunol 6(1):25. \n                    https:\/\/doi.org\/10.1186\/1710-1492-6-25","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"8670_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1185\/03007999809113354","volume":"14","author":"M Marcinkiewicz","year":"1998","unstructured":"Marcinkiewicz M, Grabowska SZ, Czyzewska E (1998) Role of epidermal growth factor (EGF) in oesophageal mucosal integrity. Curr Med Res Opin 14(3):145\u2013153. \n                    https:\/\/doi.org\/10.1185\/03007999809113354","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"8670_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaci.2015.05.045","volume":"137","author":"J Rajan","year":"2016","unstructured":"Rajan J, Newbury RO, Anilkumar A, Dohil R, Broide DH, Aceves SS (2016) Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol 137(1):147\u2013156 e148. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2015.05.045","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8670_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cgh.2007.12.045","volume":"6","author":"S Roy-Ghanta","year":"2008","unstructured":"Roy-Ghanta S, Larosa DF, Katzka DA (2008) Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 6(5):531\u2013535. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2007.12.045","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"8670_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/apt.12131","volume":"37","author":"KN Harer","year":"2013","unstructured":"Harer KN, Enders FT, Lim KG, Alexander JA, Katzka DA (2013) An allergic phenotype and the use of steroid inhalers predict eosinophilic oesophagitis in patients with asthma. Aliment Pharmacol Ther 37(1):107\u2013113. \n                    https:\/\/doi.org\/10.1111\/apt.12131","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"8670_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.anai.2015.07.004","volume":"115","author":"G Ram","year":"2015","unstructured":"Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R, Liacouras CA, Spergel JM (2015) Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 115(3):224\u2013228 e221. \n                    https:\/\/doi.org\/10.1016\/j.anai.2015.07.004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"8670_CR32","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/gut.2007.122465","volume":"56","author":"BD Havemann","year":"2007","unstructured":"Havemann BD, Henderson CA, El-Serag HB (2007) The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 56(12):1654\u20131664. \n                    https:\/\/doi.org\/10.1136\/gut.2007.122465","journal-title":"Gut"},{"issue":"4","key":"8670_CR33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1378\/chest.129.4.1051","volume":"129","author":"H Nordenstedt","year":"2006","unstructured":"Nordenstedt H, Nilsson M, Johansson S, Wallander MA, Johnsen R, Hveem K, Lagergren J (2006) The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trondelag health survey. Chest 129(4):1051\u20131056. \n                    https:\/\/doi.org\/10.1378\/chest.129.4.1051","journal-title":"Chest"},{"issue":"3","key":"8670_CR34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1378\/chest.128.3.1128","volume":"128","author":"MR Littner","year":"2005","unstructured":"Littner MR, Leung FW, Ballard ED 2nd, Huang B, Samra NK, Lansoprazole Asthma Study G (2005) Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 128(3):1128\u20131135. \n                    https:\/\/doi.org\/10.1378\/chest.128.3.1128","journal-title":"Chest"},{"issue":"10","key":"8670_CR35","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1164\/rccm.200507-1167OC","volume":"173","author":"TO Kiljander","year":"2006","unstructured":"Kiljander TO, Harding SM, Field SK, Stein MR, Nelson HS, Ekelund J, Illueca M, Beckman O, Sostek MB (2006) Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial. Am J Respir Crit Care Med 173(10):1091\u20131097. \n                    https:\/\/doi.org\/10.1164\/rccm.200507-1167OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"8670_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1164\/rccm.200910-1537OC","volume":"181","author":"TO Kiljander","year":"2010","unstructured":"Kiljander TO, Junghard O, Beckman O, Lind T (2010) Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 181(10):1042\u20131048. \n                    https:\/\/doi.org\/10.1164\/rccm.200910-1537OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"8670_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1001\/jama.2011.2035","volume":"307","author":"JT Holbrook","year":"2012","unstructured":"Writing Committee for the American Lung Association Asthma Clinical Research C, Holbrook JT, Wise RA, Gold BD, Blake K, Brown ED, Castro M, Dozor AJ, Lima JJ, Mastronarde JG, Sockrider MM, Teague WG (2012) Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 307(4):373\u2013381. \n                    https:\/\/doi.org\/10.1001\/jama.2011.2035","journal-title":"JAMA"},{"issue":"15","key":"8670_CR38","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","volume":"360","author":"JG Mastronarde","year":"2009","unstructured":"American Lung Association Asthma Clinical Research C, Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA (2009) Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360(15):1487\u20131499. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0806290","journal-title":"N Engl J Med"},{"key":"8670_CR39","doi-asserted-by":"crossref","unstructured":"Lucendo AJ, Molina-Infante J, Arias A, von Arnim U, Bredenoord AJ, Bussmann C, Dias JA, Bove M, Gonzalez-Cervera J, Larsson H, Miehlke S, Papadopoulou A, Rodr\u0131guez-Sanchez J, Ravelli A, Ronkainen A, Santander C, Schoepfer AS, Storr MA, Terreehorst I, Straumann A, Attwood SE (2017) Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J 1\u201324","DOI":"10.1177\/2050640616689525"},{"issue":"5","key":"8670_CR40","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.bpg.2015.06.009","volume":"29","author":"J Molina-Infante","year":"2015","unstructured":"Molina-Infante J, van Rhijn BD (2015) Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis. Best Pract Res Clin Gastroenterol 29(5):749\u2013758. \n                    https:\/\/doi.org\/10.1016\/j.bpg.2015.06.009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"8670_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/00365520903469931","volume":"45","author":"AL Krarup","year":"2010","unstructured":"Krarup AL, Villadsen GE, Mejlgaard E, Olesen SS, Drewes AM, Funch-Jensen P (2010) Acid hypersensitivity in patients with eosinophilic oesophagitis. Scand J Gastroenterol 45(3):273\u2013281. \n                    https:\/\/doi.org\/10.3109\/00365520903469931","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"8670_CR42","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MPG.0b013e31819c4b3e","volume":"49","author":"WN Sayej","year":"2009","unstructured":"Sayej WN, Patel R, Baker RD, Tron E, Baker SS (2009) Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 49(4):393\u2013399. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e31819c4b3e","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"8670_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MPG.0b013e31817f0197","volume":"48","author":"S Pentiuk","year":"2009","unstructured":"Pentiuk S, Putnam PE, Collins MH, Rothenberg ME (2009) Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 48(2):152\u2013160. \n                    https:\/\/doi.org\/10.1097\/MPG.0b013e31817f0197","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"8670_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.anai.2012.02.024","volume":"108","author":"J Levine","year":"2012","unstructured":"Levine J, Lai J, Edelman M, Schuval SJ (2012) Conservative long-term treatment of children with eosinophilic esophagitis. Ann Allergy Asthma Immunol 108(5):363\u2013366. \n                    https:\/\/doi.org\/10.1016\/j.anai.2012.02.024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"8670_CR45","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/gutjnl-2015-310991","volume":"65","author":"J Molina-Infante","year":"2016","unstructured":"Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, Hirano I, Katzka DA, Moawad FJ, Rothenberg ME, Schoepfer A, Spechler SJ, Wen T, Straumann A, Lucendo AJ, Oesophagitis P-RTFotESoE (2016) Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut 65(3):524\u2013531. \n                    https:\/\/doi.org\/10.1136\/gutjnl-2015-310991","journal-title":"Gut"},{"issue":"7","key":"8670_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101391","volume":"9","author":"JY Park","year":"2014","unstructured":"Park JY, Zhang X, Nguyen N, Souza RF, Spechler SJ, Cheng E (2014) Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia. PLoS One 9(7):e101391. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0101391","journal-title":"PLoS One"},{"issue":"7","key":"8670_CR47","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","volume":"146","author":"A Arias","year":"2014","unstructured":"Arias A, Gonzalez-Cervera J, Tenias JM, Lucendo AJ (2014) Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology 146(7):1639\u20131648. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2014.02.006","journal-title":"Gastroenterology"},{"issue":"5","key":"8670_CR48","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2014.05.013","volume":"134","author":"HA Sampson","year":"2014","unstructured":"Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, Nadeau K, Nowak-Wegrzyn A, Oppenheimer J, Perry TT, Randolph C, Sicherer SH, Simon RA, Vickery BP, Wood R, Joint Task Force on Practice P, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles SA, Wallace D, Practice Parameter W, Sampson HA, Aceves S, Bock SA, James J, Jones S, Lang D, Nadeau K, Nowak-Wegrzyn A, Oppenheimer J, Perry TT, Randolph C, Sicherer SH, Simon RA, Vickery BP, Wood R (2014) Food allergy: a practice parameter update\u20142014. J Allergy Clin Immunol 134(5):1016\u20131025 e1043. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2014.05.013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8670_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1053\/j.gastro.2014.04.019","volume":"147","author":"BK Butz","year":"2014","unstructured":"Butz BK, Wen T, Gleich GJ, Furuta GT, Spergel J, King E, Kramer RE, Collins MH, Stucke E, Mangeot C, Jackson WD, O'Gorman M, Abonia JP, Pentiuk S, Putnam PE, Rothenberg ME (2014) Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology 147(2):324\u2013333 e325. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2014.04.019","journal-title":"Gastroenterology"},{"issue":"4","key":"8670_CR50","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1053\/j.gastro.2016.11.021","volume":"152","author":"ES Dellon","year":"2017","unstructured":"Dellon ES, Katzka DA, Collins MH, Hamdani M, Gupta SK, Hirano I, Investigators MP (2017) Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis. Gastroenterology 152(4):776\u2013786 e775. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2016.11.021","journal-title":"Gastroenterology"},{"issue":"5","key":"8670_CR51","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jaci.2012.03.007","volume":"129","author":"S Schroeder","year":"2012","unstructured":"Schroeder S, Fleischer DM, Masterson JC, Gelfand E, Furuta GT, Atkins D (2012) Successful treatment of eosinophilic esophagitis with ciclesonide. J Allergy Clin Immunol 129(5):1419\u20131421. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2012.03.007","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8670_CR52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jaci.2012.06.053","volume":"130","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Fried AJ, Hait E, Yen EH, Perkins JM, Rubinstein E (2012) Topical inhaled ciclesonide for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 130(4):1011; author reply 1011-1012. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2012.06.053","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"8670_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/00005176-199804000-00004","volume":"26","author":"CA Liacouras","year":"1998","unstructured":"Liacouras CA, Wenner WJ, Brown K, Ruchelli E (1998) Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26(4):380\u2013385. \n                    https:\/\/doi.org\/10.1097\/00005176-199804000-00004","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"8670_CR54","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaci.2012.04.025","volume":"130","author":"LB Bacharier","year":"2012","unstructured":"Bacharier LB, Guilbert TW (2012) Diagnosis and management of early asthma in preschool-aged children. J Allergy Clin Immunol 130(2):287\u2013296; quiz 297-288. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2012.04.025","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"8670_CR55","doi-asserted-by":"publisher","first-page":"e0133428","DOI":"10.1371\/journal.pone.0133428","volume":"10","author":"YK Loke","year":"2015","unstructured":"Loke YK, Blanco P, Thavarajah M, Wilson AM (2015) Impact of inhaled corticosteroids on growth in children with asthma: systematic review and meta-analysis. PLoS One 10(7):e0133428. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0133428","journal-title":"PLoS One"},{"issue":"3","key":"8670_CR56","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1038\/ctg.2015.9","volume":"6","author":"MY Chuang","year":"2015","unstructured":"Chuang MY, Chinnaratha MA, Hancock DG, Woodman R, Wong GR, Cock C, Fraser RJ (2015) Topical steroid therapy for the treatment of eosinophilic esophagitis (EoE): a systematic review and meta-analysis. Clin Transl Gastroenterol 6(3):e82. \n                    https:\/\/doi.org\/10.1038\/ctg.2015.9","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"8670_CR57","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.2.e36","volume":"108","author":"H Milgrom","year":"2001","unstructured":"Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P (2001) Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics 108(2):E36. \n                    https:\/\/doi.org\/10.1542\/peds.108.2.e36","journal-title":"Pediatrics"},{"issue":"3","key":"8670_CR58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","volume":"60","author":"M Humbert","year":"2005","unstructured":"Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K (2005) Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60(3):309\u2013316. \n                    https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00772.x","journal-title":"Allergy"},{"issue":"6","key":"8670_CR59","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaci.2009.09.021","volume":"124","author":"B Lanier","year":"2009","unstructured":"Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF (2009) Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol 124(6):1210\u20131216. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2009.09.021","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"8670_CR60","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P, Investigators M (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371(13):1198\u20131207. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1403290","journal-title":"N Engl J Med"},{"issue":"9842","key":"8670_CR61","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","volume":"380","author":"ID Pavord","year":"2012","unstructured":"Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, Ortega H, Chanez P (2012) Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 380(9842):651\u2013659. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60988-X","journal-title":"Lancet"},{"key":"8670_CR62","doi-asserted-by":"publisher","unstructured":"Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, Wilkins HJ, Henkel T, Nair P, Res-5- Study G (2011) Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 184(10):1125\u20131132. \n                    https:\/\/doi.org\/10.1164\/rccm.201103-0396OC","DOI":"10.1164\/rccm.201103-0396OC"},{"issue":"4","key":"8670_CR63","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","volume":"150","author":"L Bjermer","year":"2016","unstructured":"Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M (2016) Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study. Chest 150(4):789\u2013798. \n                    https:\/\/doi.org\/10.1016\/j.chest.2016.03.032","journal-title":"Chest"},{"issue":"1","key":"8670_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/gut.2009.178558","volume":"59","author":"A Straumann","year":"2010","unstructured":"Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Beglinger C, Smith DA, Patel J, Byrne M, Simon HU (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59(1):21\u201330. \n                    https:\/\/doi.org\/10.1136\/gut.2009.178558","journal-title":"Gut"},{"issue":"2","key":"8670_CR65","doi-asserted-by":"publisher","first-page":"456-463","DOI":"10.1016\/j.jaci.2011.11.044","volume":"129","author":"JM Spergel","year":"2012","unstructured":"Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G 3rd, O'Gorman MA, Abonia JP, Young J, Henkel T, Wilkins HJ, Liacouras CA (2012) Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 129(2):456-463\u2013463 e451-453. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2011.11.044","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"8670_CR66","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2011.07.044","volume":"141","author":"AH Assa'ad","year":"2011","unstructured":"Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS (2011) An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 141(5):1593\u20131604. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2011.07.044","journal-title":"Gastroenterology"},{"issue":"11","key":"8670_CR67","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00431-011-1540-4","volume":"170","author":"R Rocha","year":"2011","unstructured":"Rocha R, Vitor AB, Trindade E, Lima R, Tavares M, Lopes J, Dias JA (2011) Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr 170(11):1471\u20131474. \n                    https:\/\/doi.org\/10.1007\/s00431-011-1540-4","journal-title":"Eur J Pediatr"},{"issue":"3","key":"8670_CR68","doi-asserted-by":"publisher","first-page":"e0113483","DOI":"10.1371\/journal.pone.0113483","volume":"10","author":"D Loizou","year":"2015","unstructured":"Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, Taber T, Kaushal S, Limgala R, Brown M, Gupta R, Balba N, Goker-Alpan O, Khojah A, Alpan O (2015) A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 10(3):e0113483. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0113483","journal-title":"PLoS One"},{"issue":"3","key":"8670_CR69","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","volume":"147","author":"F Clayton","year":"2014","unstructured":"Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, Lowichik A, Chen X, Emerson L, Cox K, O'Gorman MA, Peterson KA (2014) Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 147(3):602\u2013609. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2014.05.036","journal-title":"Gastroenterology"},{"key":"8670_CR70","unstructured":"Sanofi and Regeneron Pharmaceuticals I Sanofi and Regeneron announce positive phase 2 study results for dupilumab in patients with active moderate-to-severe eosinophilic esophagitis. Presented at the World Congress of Gastroenterology (WCOG) held in partnership with The American College of Gastroenterology Annual Scientific Meeting (ACG 2017) in Orlando, Florida \n                    http:\/\/www.news.sanofi.us\/Sanofi-and-Regeneron-Announce-Positive-Phase-2-Study-Results-for-Dupilumab-in-Patients-With-Active-Moderate-to-Severe-Eosinophilic-Esophagitis"},{"issue":"26","key":"8670_CR71","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, Hamilton J, Ming JE, Radin A, Stahl N, Yancopoulos GD, Graham N, Pirozzi G (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368(26):2455\u20132466. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1304048","journal-title":"N Engl J Med"},{"issue":"10039","key":"8670_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","volume":"388","author":"S Wenzel","year":"2016","unstructured":"Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, Pirozzi G, Sutherland ER, Evans RR, Joish VN, Eckert L, Graham NM, Stahl N, Yancopoulos GD, Louis-Tisserand M, Teper A (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet 388(10039):31\u201344. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)30307-5","journal-title":"Lancet"},{"issue":"12","key":"8670_CR73","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","volume":"365","author":"J Corren","year":"2011","unstructured":"Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG (2011) Lebrikizumab treatment in adults with asthma. N Engl J Med 365(12):1088\u20131098. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1106469","journal-title":"N Engl J Med"},{"issue":"10","key":"8670_CR74","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","volume":"4","author":"NA Hanania","year":"2016","unstructured":"Hanania NA, Korenblat P, Chapman KR, Bateman ED, Kopecky P, Paggiaro P, Yokoyama A, Olsson J, Gray S, Holweg CT, Eisner M, Asare C, Fischer SK, Peng K, Putnam WS, Matthews JG (2016) Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 4(10):781\u2013796. \n                    https:\/\/doi.org\/10.1016\/S2213-2600(16)30265-X","journal-title":"Lancet Respir Med"},{"issue":"2","key":"8670_CR75","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2014.07.049","volume":"135","author":"ME Rothenberg","year":"2015","unstructured":"Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, Nadeau K, Kaiser S, Peters T, Perez A, Jones I, Arm JP, Strieter RM, Sabo R, Gunawardena KA (2015) Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 135(2):500\u2013507. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2014.07.049","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8670_CR76","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s12325-017-0525-8","volume":"34","author":"CS Tripp","year":"2017","unstructured":"Tripp CS, Cuff C, Campbell AL, Hendrickson BA, Voss J, Melim T, Wu C, Cherniack AD, Kim K (2017) RPC4046, a novel anti-interleukin-13 antibody, blocks IL-13 binding to IL-13 alpha1 and alpha2 receptors: a randomized, double-blind, placebo-controlled, dose-escalation first-in-human study. Adv Ther 34(6):1364\u20131381. \n                    https:\/\/doi.org\/10.1007\/s12325-017-0525-8","journal-title":"Adv Ther"},{"issue":"10056","key":"8670_CR77","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","volume":"388","author":"ER Bleecker","year":"2016","unstructured":"Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkstrom V, Goldman M, investigators Ss (2016) Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388(10056):2115\u20132127. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)31324-1","journal-title":"Lancet"},{"issue":"10056","key":"8670_CR78","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","volume":"388","author":"JM FitzGerald","year":"2016","unstructured":"FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkstrom V, Aurivillius M, Goldman M, investigators Cs (2016) Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 388(10056):2128\u20132141. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)31322-8","journal-title":"Lancet"},{"issue":"4","key":"8670_CR79","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5114\/aoms.2012.30280","volume":"8","author":"J Mathew","year":"2012","unstructured":"Mathew J, Aronow WS, Chandy D (2012) Therapeutic options for severe asthma. Arch Med Sci 8(4):589\u2013597. \n                    https:\/\/doi.org\/10.5114\/aoms.2012.30280","journal-title":"Arch Med Sci"},{"issue":"5","key":"8670_CR80","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12282-013-0514-y","volume":"22","author":"HM Baek","year":"2015","unstructured":"Baek HM, Lee YJ (2015) Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner. Breast Cancer 22(5):510\u2013519. \n                    https:\/\/doi.org\/10.1007\/s12282-013-0514-y","journal-title":"Breast Cancer"},{"issue":"10","key":"8670_CR81","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/MEG.0b013e32825a6ab4","volume":"19","author":"P Netzer","year":"2007","unstructured":"Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM (2007) Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 19(10):865\u2013869. \n                    https:\/\/doi.org\/10.1097\/MEG.0b013e32825a6ab4","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-018-8670-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-018-8670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-018-8670-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T18:11:59Z","timestamp":1589739119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-018-8670-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,18]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["8670"],"URL":"https:\/\/doi.org\/10.1007\/s12016-018-8670-7","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,18]]},"assertion":[{"value":"18 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Durrani reports funding from Sanofi\/Regeneron.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Mukkada reports funding from the NIH, PCORI, and Shire. He has done consulting work with hire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Guilbert reports personal fees from the American Board of Pediatrics; Pediatric Pulmonary Subboard, personal fees from Teva, personal fees from GSK, personal fees from Regeneron Pharmaceuticals, grants from NIH, other from UpToDate, personal fees from Merck, grants and personal fees from Sanofi\/Regeneron, personal fees from Novartis\/Regeneron, personal fees from Aviragen, and personal fees from GSK\/Regneron, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}